NeuroPace, Inc. (NPCE) News
Track canonical SquawkNews coverage tagged to NPCE, NeuroPace, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
NeuroPace Raises FY2026 Sales Guidance from $99.000M-$101.000M to $99.500M-$101.500M vs $99.913M Est
NeuroPace (NASDAQ: NPCE ) raises FY2026 sales outlook from $99.000 million-$101.000 million to $99.500 million-$101.500 million vs $99.913 million estimate.
EARNINGS | Aug 11, 2026, 08:08 PM UTC
L
NeuroPace Q2 EPS $(0.18) Beats $(0.20) Estimate, Sales $22.826M Beat $22.654M Estimate
NeuroPace (NASDAQ: NPCE ) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 30.77 percent increase over losses of $(0.26) per share from the same
EARNINGS | Aug 11, 2026, 08:07 PM UTC
L
NPCE -7% premarket after FDA headlines
NPCE -7% premarket after FDA headlines
REGULATION | Jul 29, 2026, 12:47 PM UTC
H
Avis Budget Posts Weak Q2 Results, Joins Fiverr International, Costar Group And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Sess
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Wednesday. Shares of Avis Budget Group Inc (NASDAQ: CAR ) fell sharply in pre-market trading after the company reported worse-than-e
EARNINGS | Jul 29, 2026, 12:03 PM UTC
L
NPCE Neuropace receives FDA guidance on pma supplement for indication expansion into idiopathic generalized epilepsy
NPCE Neuropace receives FDA guidance on pma supplement for indication expansion into idiopathic generalized epilepsy
EARNINGS | Jul 28, 2026, 08:01 PM UTC
L
NPCE Initiated Outperform W/$22.00 PT at Mizuho
NPCE Initiated Outperform W/$22.00 PT at Mizuho
EQUITY | Jul 23, 2026, 11:55 AM UTC
L
NPCE new Outperform W/ $22 PT @ Mizuho
NPCE new Outperform W/ $22 PT @ Mizuho
EQUITY | Jul 23, 2026, 11:38 AM UTC